Surrogate viruses for use in disinfectant efficacy tests to justify claims against COVID-19

Name: Surrogate viruses for use in disinfectant efficacy tests to justify claims against COVID-19
Creator: Therapeutic Goods Administration
Keywords: claims,coronavirus,covid,covid-19,disinfectants,faq,frequently-asked-questions,guidances,sars-cov-2,viruses

Information

Original link

Type

Guidance

Regulated products

Medical Devices

Topics

Advertising, COVID

Published

July 7, 2022

Last updated

July 7, 2022

Description

Frequently asked questions added

Organization

Therapeutic Goods Administration (TGA) 🇦🇺

Country / Region

Australia

License

Other (Non-Commercial)

Feedback

Suggest an improvement to this page

1 Main file

Surrogate viruses for use in disinfectant efficacy tests to justify claims against COVID-19

Updated on July 7, 2022

html

URL: https://www.tga.gov.au/resources/resource/guidance/surrogate-viruses-use-disinfectant-efficacy-tests-justify-claims-against-covid-19
Permalink: https://data.openrid.co/en/datasets/r/55e3c986-b79f-47ca-859d-cc5b45a69443
MIME Type: text/html

Created on: July 7, 2022
Modified on: July 7, 2022

Surrogate viruses for use in disinfectant efficacy tests to justify claims against COVID-19

Information

Type

Regulated products

Topics

Published

Last updated

Description

Tags

Organization

Country / Region

License

Feedback

Actions

Social networks

Embed